Two drugmakers said Friday their COVID-19 vaccine candidate won’t be ready until late 2021.
GlaxoSmithKline and Sanofi said interim results from a combined phase one/phase two clinical trial showed an “insufficient response” in older adults.
Vials are seen on a pdocution line at the factory of GlaxoSmithKline in Saint-Amand-les-Eaux, northern France, on Dec. 3, 2020. Fancois Lo Presti/AFP via Getty Images
Zachary Stieber
Senior Reporter
|Updated:
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
Author’s Selected Articles
